COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 653: Articles 6521-6530  | Next

The impact of COVID-19 on population cancer screening programs in Australia: modelled evaluations for breast, bowel and cervical cancer
Nickson, C., Smith, M. A., Feletto, E., Velentzis, L. S., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D. J., Lew, J.-B., Procopio, P., Simms, K., Worthington, J., Mann, G. B., Canfell, K.
10.1101/2022.09.11.22279831 — Posted: 2022-09-15
Angiotensin 1-7 in severe COVID-19 patients: a phase 1 clinical trial
Valle Martins, A. L., Annoni, F., da Silva, F. A., Bolais-Ramos, L., Capanema de Oliveira, G., dos Santos Matos, A. H., Jardim Heyden, M. C., Dias Pinheiro, B., Abdo Rodrigues, N., Alves Pereira, D. A., Lana Diniz, M. M., Granato Fonseca Silva, T., Carvalho Cardoso, A., Carvalho Martins, J., Motta-Santos, D., Campagnole-Santos, M. J., Verano-Braga, T., Taccone, F. S., Santos, R. A. S.
10.1101/2022.09.15.22279897 — Posted: 2022-09-15
Real-world Use of Nirmatrelvir-Ritonavir in COVID-19 Outpatients During the Emergence of Omicron Variants BA.2/BA2.12.1
Aggarwal, N. R., Molina, K., Beaty, L., Bennett, T. D., Carlson, N., Ginde, A. A.
10.1101/2022.09.12.22279866 — Posted: 2022-09-15
Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney Diseases
Leung, D., Chan, E. Y. H., Mu, X., Rosa Duque, J. S., Cheng, S. M., Ho, F. T.-w., Tong, P.-c., Lai, W.-m., Lee, M. H., Chim, S., Tam, I. Y., Tsang, L. C., Kwan, K. K., Chung, Y., Wong, H. H., Lee, A. M., Sze, S. T., Lam, J. H., Lee, D. H., Chan, S. M., Tu, W., Peiris, J. S. M., Ma, A. L.-t., Lau, Y. L.
10.1101/2022.09.14.22279916 — Posted: 2022-09-15
Assessing the Impacts of COVID-19 and Social Isolation on Mental Health in the United States of America
Fulk, A., Saenz-Escarcega, R., Kobayashi, H., Maposa, I., Agusto, F.
10.1101/2022.09.09.22277383 — Posted: 2022-09-14
Excess mortality in the general population versus Veterans Healthcare System during the first year of the COVID-19 pandemic in the United States
Weinberger, D. M., Rose, L., Rentsch, C. T., Asch, S. M., Columbo, J. A., King, J. T., Korves, C., Lucas, B. P., Taub, C. C., Young-Xu, Y., Vashi, A., Davies, L., Justice, A. C.
10.1101/2022.09.13.22279868 — Posted: 2022-09-14
Analysis and comprehensive lineage identification for SARS-CoV-2 genomes through scalable learning methods
Cahuantzi, R., Lythgoe, K., Hall, I., House, T. A., Pellis, L.
10.1101/2022.09.14.507985 — Posted: 2022-09-14
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Rodriguez-Aponte, S. A., Dalvie, N. C., Wong, T. Y., Johnston, R. S., Naranjo, C. A., Bajoria, S., Kumru, O. S., Kaur, K., Russ, B. P., Lee, K. S., Cyphert, H. A., Barbier, M., Rao, H. D., Rajurkar, M. P., Lothe, R. R., Shaligram, U., Batwal, S., Chandrasekaran, R., Nagar, G., Kleanthous, H., Biswas, S., Bevere, J. R., Joshi, S. B., Volkin, D. B., Damron, F. H., Love, J. C.
10.1101/2022.09.14.507842 — Posted: 2022-09-14
The Effects of Long COVID-19, its Severity, and the Need for Immediate Attention: Analysis of Clinical Trials and Twitter data
Bhattacharyya, A., Seth, A., Rai, S.
10.1101/2022.09.13.22279833 — Posted: 2022-09-14
Real-World Effectiveness of Nirmatrelvir/Ritonavir in Preventing Hospitalization Among Patients With COVID-19 at High Risk for Severe Disease in the United States: A Nationwide Population-Based Cohort Study
Zhou, X., Kelly, S. P., Liang, C., Li, L., Shen, R., Leister-Tebbe, H., Terra, S. G., Gaffney, M., Russo, L. J.
10.1101/2022.09.13.22279908 — Posted: 2022-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).